Description
Cagrilintide 5 mg — Opti-Gen Peptides
For laboratory research use only.
Not for human use. Not for veterinary use.
Not licensed by the MHRA. Not a medicinal product.
Research-grade synthetic peptide supplied as a 5 mg sealed vial for lawful laboratory research in the UK. Catalogue label: CARGRILLINTIDE. Not a food, supplement or medical device on this page. Not for diagnostic or therapeutic use. Must not be administered to people or animals.
This vial is not semaglutide, tirzepatide or pramlintide and is not an authorised medicine.
Identification
| Product name (label) | Cargrillintide |
| Research / INN name | Cagrilintide |
| Also listed as | Long-acting amylin analogue (research ligand) |
| Supplier | Opti-Gen Peptides |
| Contents | 5 mg per vial |
| CAS | 1415456-99-3 |
| Approx. mass | ~4409 Da |
| Intended use | Laboratory / in-vitro research only |
Confirm identity on the lot COA.
Quality / storage
Only the lot COA applies. Store as a laboratory peptide under institutional SOP. No pen, dose or injection instructions on this page.
Published research context (not product claims)
Cagrilintide is a long-acting amylin receptor analogue from Novo Nordisk chemistry. Receptor papers describe amylin / calcitonin-family pharmacology in experimental systems.
Clinical-development publications cover obesity and combination programmes (including work with GLP-1 analogues). Those papers concern investigational or licensed-programme products, not this research vial.
Combination branding such as CagriSema refers to regulated development products. It must not be used as a claim or keyword for this listing.
There is no UK marketing authorisation for this research vial.
UK notice
18+. Buyer confirms lawful laboratory research use only and will not use or resell for unauthorised human or animal use.
Reviews
There are no reviews yet.